Ruffer LLP

SEC CIK: 0001426859
Latest filing: Jul 30, 2026

SEC filings (opens in a new tab)

SUPN holding history

Supernus Pharmaceuticals, Inc. in every 13F filed by Ruffer LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SUPN overview All 13F holders of SUPN Full Q2 2026 holdings

Shares (Q1 2026): 0; Sold out in Q1 2026
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q3 2025

Holdings of SUPN by Ruffer LLP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2026	0	$0	0.0%	−34,327−100.0%	Sold out	Holders
Q4 2025	34,327	$1.71M	0.1%	−21,058−38.0%	Reduced	Holders
Q3 2025	55,385	$2.65M	0.1%	+55,385	New	Holders